Aussies buy Tower's health insurance business

Last updated 10:19 02/11/2012
TWR 1.990 0.00 0.00%

Click for a detailed chart

Relevant offers


Marlborough wine exporters welcome TPP Media boss pleads guilty to fraud Apple and Google top the world's 'best brands' Savvy customers force companies to cut prices at highest level since 1999 TPPA 'bigger opportunity than China free trade deal' says Business NZ No increased medicine costs under TPPA ANZ had 3% of workers breach code of conduct in 2014 NZ dollar supported but not by TPP Stark Property breathes new life into Knox St building Wool merger could lead to 'hundreds' of job losses, Godfrey Hirst warns

Listed insurer Tower has sold its health insurance business for $102 million to Australian listed company NIB Holdings.

Tower group managing director Rob Flannagan said the sale of Tower Medical Insurance followed a strategic review of the group's business, announced earlier in the year.

“We have carefully assessed our involvement in and outlook for each of the insurance markets in which Tower operates.

"We do not consider that we will be able to achieve the necessary scale or return in this business in the immediate future, and therefore have made the strategic decision to sell Tower Medical Insurance.”

Mark Fitzgibbon, managing director of ASX-listed NIB, said the acquisition was in line with its strategy of expanding into international markets.

“NIB has been investigating opportunities in New Zealand for some time. Tower Medical meets NIB's strict investment criteria in terms of strategic rationale and return on investment,” Fitzgibbon said.

Flannagan said the Tower board was satisfied with the sale price of approximately $102m that had been achieved. It intended repaying capital to shareholders of not less than the proceeds of the sale.

The sale is subject to Overseas Investment Office approval. Settlement is likely before December 31.

Tower said it expects group net profit after tax for the year ended September 30 to exceed the upper end of published analyst ranges.

Net profit after tax is expected to be in the range of $51 million to $56 million.

Ad Feedback


Special offers

Featured Promotions

Sponsored Content